Cargando…
Parthenolide inhibits the growth of non-small cell lung cancer by targeting epidermal growth factor receptor
BACKGROUND: EGFR tyrosine kinase inhibitors (TKIs) have been developed for the treatment of EGFR mutated NSCLC. Parthenolide, a natural product of parthenolide, which belongs to the sesquiterpene lactone family and has a variety of biological and therapeutic activities, including anti-cancer effects...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7686780/ https://www.ncbi.nlm.nih.gov/pubmed/33292235 http://dx.doi.org/10.1186/s12935-020-01658-1 |